✦ LIBER ✦

Guidance on the use of miglustat for treating patients with type 1 Gaucher disease

✍ Scribed by Neal J. Weinreb; John A. Barranger; Joel Charrow; Gregory A. Grabowski; Henry J. Mankin; Pramod Mistry

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 101 KB
Volume: 80
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A benchmark analysis of the achievement

A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase

✍ Neal Weinreb; John Taylor; Timothy Cox; John Yee; Stephan vom Dahl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Markers for type II collagen breakdown p

Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis

✍ Robert Landewé; Piet Geusens; Maarten Boers; Désirée van der Heijde; Willem Lems 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective To investigate in a randomized clinical trial setting with an aggressive combination‐therapy arm and a mild‐monotherapy arm, whether therapy‐induced changes in urinary C‐terminal crosslinking telopeptide of type I collagen (CTX‐I) and type II collagen (CTX‐II) predict 5‐ye

Use of genetic typing versus other marke

Use of genetic typing versus other markers for predicting outcome in patients with inflammatory arthritis: comment on the article by Gough et al

✍ D. Lilic; J. N. Fordham 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB 👁 2 views

Use of acetaminophen in the treatment of

Use of acetaminophen in the treatment of osteoarthritis in patients with liver disease: Comment on the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis

✍ Joseph M. Lynch; Tiziana M. Fox 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Compound heterozygosity for a disease-ca

Compound heterozygosity for a disease-causing G1489D and disease-modifying G530S substitution inCOL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: An explanation of intrafamilial variability?

✍ Giunta, Cecilia; Steinmann, Beat 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

The classical type of Ehlers-Danlos syndrome (EDS) is an autosomal dominant connective tissue disorder characterized by skin hyperelasticity, tissue fragility, and joint hypermobility. We investigated the molecular defect of EDS in a three-generation family. Cultured dermal fibroblasts from the prop

Homozygous state for a new single bp-del

Homozygous state for a new single bp-deletion (g.787delA) in exon 5 of the glucose-6-phosphatase gene in a patient with early onset of glycogen storage disease type 1a

✍ M. Linnebank; B. Rapp; A. Homberger; C. Winter; T. Marquardt; U. Künzel; H.G. Ko 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 10 KB 👁 2 views